ASRT vs C · rev $125.0M vs P/E 16, rev $85.22B
Assertio Therapeutics Inc (ASRT) versus Citigroup Inc. (C) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
ASRT currently screens at market cap $151.5M. C currently screens at market cap $214.73B and trailing P/E 15.5.
Not investment advice. Open the ASRT and C stock pages for the full models.
Not investment advice.